YME-17039-87234 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-07-19
Registered in v-safe
2021-07-19
Dose 1 — Pfizer-BioNTech
2021-07-19
Health check-in — day 0, dose 1
Feeling: Fair · None

Adult check-in
2021-07-20
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Redness · Muscle or body aches

Adult check-in
2021-07-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-07-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-08-09
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-10-20
Survey response — 3 months, dose 1
MedDRA: Seizure — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Seizure

MedDRA releases: 2024-11 · check-in free text available
2022-07-21
Health check-in — 12 months, dose 1
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-07-19	Pfizer-BioNTech	No

Free text

Release 10 — 3 months, dose 1

2021-10-20

Symptoms: Seizure

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Seizure	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release